3.24
price down icon2.99%   -0.10
after-market After Hours: 3.39 0.15 +4.63%
loading

Grace Therapeutics Inc Stock (GRCE) Forecast

The Grace Therapeutics Inc (GRCE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $3.24. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GRCE Price Target
Average 0.00 (-100.00% Downside)
loading

Is Grace Therapeutics Inc (GRCE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 41.11 Neutral
STOCH(9,6) 33.68 Neutral
STOCHRSI(14) 24.68 Neutral
MACD(12,26) -0.1324 Sell
ADX(14) 21.72 Neutral
William %R -72.38 Neutral
CCI(14) -50.04 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.3599
Sell
3.3793
Sell
MA20
3.5557
Sell
3.5057
Sell
MA50
3.7189
Sell
3.5283
Sell
MA100
2.4241
Buy
0.00
Buy
MA200
1.212
Buy
0.00
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, GRCE could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on GRCE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 41.11 indicates that GRCE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 33.68 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.68 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 21.72 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.04 indicates that GRCE is still oversold but not to an extreme extent.

Grace Therapeutics Inc Stock (GRCE) Year by Year Forecast

$74.13
price down icon 1.09%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Cap:     |  Volume (24h):